|
HY-136824-1mg
|
MedChemexpress LLC
|
Napyradiomycin A1 [CAS 103106-24-7]
|
|
COVID-19-immunoregulation
|
|
|
HY-113432-5mg
|
MedChemexpress LLC
|
Nudifloramide [CAS 701-44-0]
|
|
Neuroscience-Neuromodulation
|
|
|
HY-113432-1mL
|
MedChemexpress LLC
|
Nudifloramide [CAS 701-44-0] (10mM in DMSO)
|
|
Neuroscience-Neuromodulation
|
|
|
HY-113432S-1mg
|
MedChemexpress LLC
|
Nudifloramide-d3 [CAS 1207384-48-2]
|
|
Metabolism-protein/nucleotide metabolism
|
|
|
HY-113432S-5mg
|
MedChemexpress LLC
|
Nudifloramide-d3 [CAS 1207384-48-2]
|
|
Metabolism-protein/nucleotide metabolism
|
|
|
HY-138800-100mg
|
MedChemexpress LLC
|
Spinosad [CAS 168316-95-8]
|
|
Neuroscience-Neuromodulation
|
|
|
HY-138800-500mg
|
MedChemexpress LLC
|
Spinosad [CAS 168316-95-8]
|
|
Neuroscience-Neuromodulation
|
|
|
HY-125954A-100mg
|
MedChemexpress LLC
|
Uridine diphosphate glucuronic acid (ammonium) [CAS 43195-60-4]
|
|
Metabolism-sugar/lipid metabolism
|
|
|
HY-125954A-25mg
|
MedChemexpress LLC
|
Uridine diphosphate glucuronic acid (ammonium) [CAS 43195-60-4]
|
|
Metabolism-sugar/lipid metabolism
|
|
|
HY-125954A-50mg
|
MedChemexpress LLC
|
Uridine diphosphate glucuronic acid (ammonium) [CAS 43195-60-4]
|
|
Metabolism-sugar/lipid metabolism
|
|
|
HY-126307-10mg
|
MedChemexpress LLC
|
Urolithin B [CAS 1139-83-9]
|
|
|
|
|
HY-126307-100mg
|
MedChemexpress LLC
|
Urolithin B [CAS 1139-83-9]
|
|
|
|
|
HY-126307-5mg
|
MedChemexpress LLC
|
Urolithin B [CAS 1139-83-9]
|
|
|
|
|
HY-126307-50mg
|
MedChemexpress LLC
|
Urolithin B [CAS 1139-83-9]
|
|
|
|
|
HY-126307-1mL
|
MedChemexpress LLC
|
Urolithin B [CAS 1139-83-9] (10mM in DMSO)
|
|
|
|
|
HY-D0020-100mg
|
MedChemexpress LLC
|
2,2'-Bipyridine [CAS 366-18-7]
|
|
|
|
|
HY-D0020-1mL
|
MedChemexpress LLC
|
2,2'-Bipyridine [CAS 366-18-7] (10mM in DMSO)
|
|
|
|
|
HY-N7069-10mg
|
MedChemexpress LLC
|
4-Isopropylbenzyl alcohol [CAS 536-60-7]
|
|
Cancer-programmed cell death
|
|
|
HY-N7069-5mg
|
MedChemexpress LLC
|
4-Isopropylbenzyl alcohol [CAS 536-60-7]
|
|
Cancer-programmed cell death
|
|
|
HY-N7069-50mg
|
MedChemexpress LLC
|
4-Isopropylbenzyl alcohol [CAS 536-60-7]
|
|
Cancer-programmed cell death
|
|
|
HY-150156-10mg
|
MedChemexpress LLC
|
Anti-inflammatory agent 32 [CAS 2577388-38-4]
|
|
COVID-19-immunoregulation
|
|
|
HY-150156-100mg
|
MedChemexpress LLC
|
Anti-inflammatory agent 32 [CAS 2577388-38-4]
|
|
COVID-19-immunoregulation
|
|
|
HY-150156-25mg
|
MedChemexpress LLC
|
Anti-inflammatory agent 32 [CAS 2577388-38-4]
|
|
COVID-19-immunoregulation
|
|
|
HY-150156-5mg
|
MedChemexpress LLC
|
Anti-inflammatory agent 32 [CAS 2577388-38-4]
|
|
COVID-19-immunoregulation
|
|
|
HY-150156-50mg
|
MedChemexpress LLC
|
Anti-inflammatory agent 32 [CAS 2577388-38-4]
|
|
COVID-19-immunoregulation
|
|
